140 related articles for article (PubMed ID: 11106348)
1. MMP1 and MMP3 polymorphisms in promoter regions and cancer.
Biondi ML; Turri O; Leviti S; Seminati R; Cecchini F; Bernini M; Ghilardi G; Guagnellini E
Clin Chem; 2000 Dec; 46(12):2023-4. PubMed ID: 11106348
[No Abstract] [Full Text] [Related]
2. Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma.
Lièvre A; Milet J; Carayol J; Le Corre D; Milan C; Pariente A; Nalet B; Lafon J; Faivre J; Bonithon-Kopp C; Olschwang S; Bonaiti-Pellié C; Laurent-Puig P;
BMC Cancer; 2006 Nov; 6():270. PubMed ID: 17125518
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis.
Bradbury PA; Zhai R; Hopkins J; Kulke MH; Heist RS; Singh S; Zhou W; Ma C; Xu W; Asomaning K; Ter-Minassian M; Wang Z; Su L; Christiani DC; Liu G
Carcinogenesis; 2009 May; 30(5):793-8. PubMed ID: 19321798
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects.
McColgan P; Sharma P
Int J Cancer; 2009 Sep; 125(6):1473-8. PubMed ID: 19507256
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
Woo M; Park K; Nam J; Kim JC
J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
[TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis.
Liu D; Guo H; Li Y; Xu X; Yang K; Bai Y
PLoS One; 2012; 7(2):e31251. PubMed ID: 22348060
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer.
Decock J; Paridaens R; Ye S
Clin Genet; 2008 Mar; 73(3):197-211. PubMed ID: 18177467
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.
Peng B; Cao L; Wang W; Xian L; Jiang D; Zhao J; Zhang Z; Wang X; Yu L
Mutagenesis; 2010 Jan; 25(1):41-8. PubMed ID: 19843588
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
Padala C; Tupurani MA; Puranam K; Gantala S; Shyamala N; Kondapalli MS; Gundapaneni KK; Mudigonda S; Galimudi RK; Kupsal K; Nanchari SR; Chavan U; Chinta SK; Mukta S; Satti V; Hanumanth SR
PLoS One; 2017; 12(9):e0184448. PubMed ID: 28961241
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P
Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394
[TBL] [Abstract][Full Text] [Related]
12. [Polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 in colorectal cancer].
Araki A; Hazama S; Oka M; Hinoda Y
Nihon Rinsho; 2003 Sep; 61 Suppl 7():229-32. PubMed ID: 14574887
[No Abstract] [Full Text] [Related]
13. No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in Chinese.
Xu E; Lai M; Lŭ B; Xing X; Huang Q
Dis Colon Rectum; 2006 Sep; 49(9):1439-44. PubMed ID: 16937230
[TBL] [Abstract][Full Text] [Related]
14. A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer.
Six L; Grimm C; Leodolter S; Tempfer C; Zeillinger R; Sliutz G; Speiser P; Reinthaller A; Hefler LA
Gynecol Oncol; 2006 Mar; 100(3):506-10. PubMed ID: 16214204
[TBL] [Abstract][Full Text] [Related]
15. The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China.
Shan K; Ying W; Jian-Hui Z; Wei G; Na W; Yan L
Mol Hum Reprod; 2005 Jun; 11(6):423-7. PubMed ID: 15879464
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins.
Kurzawski M; Modrzejewski A; Pawlik A; Droździk M
Clin Exp Dermatol; 2009 Jul; 34(5):613-7. PubMed ID: 19508478
[TBL] [Abstract][Full Text] [Related]
17. Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis.
Dörr S; Lechtenböhmer N; Rau R; Herborn G; Wagner U; Müller-Myhsok B; Hansmann I; Keyszer G
Arthritis Res Ther; 2004; 6(3):R199-207. PubMed ID: 15142265
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
Slattery ML; John E; Torres-Mejia G; Stern M; Lundgreen A; Hines L; Giuliano A; Baumgartner K; Herrick J; Wolff RK
PLoS One; 2013; 8(5):e63165. PubMed ID: 23696797
[TBL] [Abstract][Full Text] [Related]
19. No evidence indicated that polymorphisms of the matrix metalloproteinases genes were associated with breast cancer risk: an update.
He T
Breast Cancer Res Treat; 2011 Jul; 128(2):589-91. PubMed ID: 21336947
[No Abstract] [Full Text] [Related]
20. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.
Cozzolino M; Biondi ML; Galassi A; Turri O; Brancaccio D; Gallieni M
Nephrol Dial Transplant; 2009 Jul; 24(7):2207-12. PubMed ID: 19221176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
